GATA6 loss-of-function mutations contribute to familial dilated cardiomyopathy

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1315-1322

  Xu, Lei ^a   Zhao, Lan ^b   Yuan, Fang ^a   Jiang, Wei Feng ^a   Liu, Hua ^a   Li, Ruo Gu ^a   Xu, Ying Jia ^a   Zhang, Min ^a   Fang, Wei Yi ^a   Qu, Xin Kai ^a   Yang, Yi Qing ^a   Qiu, Xing Biao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b YANTAISHAN HOSPITAL   (China)

Author keywords

Dilated cardiomyopathy; GATA6; Genetics; Reporter gene analysis; Transcription factor

Indexed keywords

AMINO ACID; TRANSCRIPTION FACTOR GATA 6; ZINC FINGER PROTEIN; GATA6 PROTEIN, HUMAN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXON; FAMILIAL DILATED CARDIOMYOPATHY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HUMAN CELL; INTRON; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE; PRENATAL PERIOD; PROPHYLAXIS; SPECIES; TRANSCRIPTION INITIATION; WILD TYPE; AGED; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PROSPECTIVE STUDY; SEQUENCE ALIGNMENT;

ADULT; AGED; AMINO ACID SEQUENCE; CARDIOMYOPATHY, DILATED; EXONS; FEMALE; GATA6 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; INTRONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; PROSPECTIVE STUDIES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSCRIPTIONAL ACTIVATION;

EID: 84907226738     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1896     Document Type: Article

References (53)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE and Young JB; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention: Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807-1816, 2006.
2. Sen-Chowdhry S and McKenna WJ: Sudden death from genetic and acquired cardiomyopathies. Circulation 125: 1563-1576, 2012.
3. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD and Lipshultz SE: Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296: 1867-1876, 2006.
4. McNally EM, Golbus JR and Puckelwartz MJ: Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 123: 19-26, 2013.
5. Refaat MM, Lubitz SA, Makino S, Islam Z, Frangiskakis JM, Mehdi H, Gutmann R, Zhang ML, Bloom HL, MacRae CA, Dudley SC, Shalaby AA, Weiss R, McNamara DM, London B and Ellinor PT: Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm 9: 390-396, 2012.
6. Disertori M, Quintarelli S, Grasso M, Pilotto A, Narula N, Favalli V, Canclini C, Diegoli M, Mazzola S, Marini M, Del Greco M, Bonmassari R, Masè M, Ravelli F, Specchia C and Arbustini E: Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A. Circ Cardiovasc Genet 6: 27-36, 2013.
7. Paavola J, Schliffke S, Rossetti S, Kuo IY, Yuan S, Sun Z, Harris PC, Torres VE and Ehrlich BE: Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J Mol Cell Cardiol 58: 199-208, 2013.
8. Wahbi K, Béhin A, Bécane HM, Leturcq F, Cossée M, Laforet P, Stojkovic T, Carlier P, Toussaint M, Gaxotte V, Cluzel P, Eymard B and Duboc D: Dilated cardiomyopathy in patients with mutations in anoctamin 5. Int J Cardiol 168: 76-79, 2013.
9. Oka T, Xu J and Molkentin JD: Re-employment of developmental transcription factors in adult heart disease. Semin Cell Dev Biol 18: 117-131, 2007.
10. Molkentin JD: The zinc finger-containing transcription factors GATA-4,-5, and-6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275: 38949-38952, 2000.
11. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE and Molkentin JD: The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276: 30245-30253, 2001.
12. van Berlo JH, Elrod JW, van den Hoogenhof MM, York AJ, Aronow BJ, Duncan SA and Molkentin JD: The transcription factor GATA-6 regulates pathological cardiac hypertrophy. Circ Res 107: 1032-1040, 2010.
13. Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, Kang PM, Izumo S and Pu WT: Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 103: 14471-14476, 2006.
14. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA and Molkentin JD: Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98: 837-845, 2006.
15. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447, 2003.
16. Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V, Srivastava D, Goldmuntz E, Broman KW, Benson DW, Smoot LB and Pu WT: Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 43: 677-685, 2007.
17. Wang J, Fang M, Liu XY, Xin YF, Liu ZM, Chen XZ, Wang XZ, Fang WY, Liu X and Yang YQ: A novel GATA4 mutation responsible for congenital ventricular septal defects. Int J Mol Med 28: 557-564, 2011.
18. Liu XY, Wang J, Zheng JH, Bai K, Liu ZM, Wang XZ, Liu X, Fang WY and Yang YQ: Involvement of a novel GATA4 mutation in atrial septal defects. Int J Mol Med 28: 17-23, 2011.
19. McCulley DJ and Black BL: Transcription factor pathways and congenital heart disease. Curr Top Dev Biol 100: 253-277, 2012.
20. Yang YQ, Gharibeh L, Li RG, Xin YF, Wang J, Liu ZM, Qiu XB, Xu YJ, Xu L, Qu XK, Liu X, Fang WY, Huang RT, Xue S and Nemer G: GATA4 loss-of-function mutations underlie familial tetralogy of Fallot. Hum Mutat 34: 1662-1671, 2013.
21. Posch MG, Boldt LH, Polotzki M, Richter S, Rolf S, Perrot A, Dietz R, Ozcelik C and Haverkamp W: Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur J Med Genet 53: 201-203, 2010.
22. Jiang JQ, Shen FF, Fang WY, Liu X and Yang YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol Med 28: 1025-1032, 2011.
23. Wang J, Sun YM and Yang YQ: Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation. Mol Biol Rep 39: 8127-8135, 2012.
24. Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X, Xu YJ, Jiang WF, Jiang JQ, Liu X, Fang WY, Zhang M, Peng LY, Qu XK and Yang YQ: GATA4 loss-of-function mutation underlies familial dilated cardiomyopathy. Biochem Biophys Res Commun 439: 591-596, 2013.
25. Zhao L, Xu JH, Xu WJ, Yu H, Wang Q, Zheng HZ, Jiang WF, Jiang JF and Yang YQ: A novel GATA4 loss-of-function mutation responsible for familial dilated cardiomyopathy. Int J Mol Med 33: 654-660, 2014.
26. Kodo K, Nishizawa T, Furutani M, Arai S, Yamamura E, Joo K, Takahashi T, Matsuoka R and Yamagishi H: GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci USA 106: 13933-13938, 2009.
27. Lin X, Huo Z, Liu X, Zhang Y, Li L, Zhao H, Yan B, Liu Y, Yang Y and Chen YH: A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. J Hum Genet 55: 662-667, 2010.
28. Maitra M, Koenig SN, Srivastava D and Garg V: Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr Res 68: 281-285, 2010.
29. Wang J, Luo XJ, Xin YF, Liu Y, Liu ZM, Wang Q, Li RG, Fang WY, Wang XZ and Yang YQ: Novel GATA6 mutations associated with congenital ventricular septal defect or tetralogy of fallot. DNA Cell Biol 31: 1610-1617, 2012.
30. Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ and Liu XY: A novel GATA6 mutation associated with congenital ventricular septal defect. Int J Mol Med 29: 1065-1071, 2012.
31. Huang RT, Xue S, Xu YJ and Yang YQ: Somatic mutations in the GATA6 gene underlie sporadic tetralogy of Fallot. Int J Mol Med 31: 51-58, 2013.
32. Yang YQ, Wang XH, Tan HW, Jiang WF, Fang WY and Liu X: Prevalence and spectrum of GATA6 mutations associated with familial atrial fibrillation. Int J Cardiol 155: 494-496, 2012.
33. Li J, Liu WD, Yang ZL and Yang YQ: Novel GATA6 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med 30: 783-790, 2012.
34. Yang YQ, Li L, Wang J, Zhang XL, Li RG, Xu YJ, Tan HW, Wang XH, Jiang JQ, Fang WY and Liu X: GATA6 loss-of-function mutation in atrial fibrillation. Eur J Med Genet 55: 520-526, 2012.
35. Elliott P, O'Mahony C, Syrris P, Evans A, Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A and McKenna WJ: Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ Cardiovasc Genet 3: 314-322, 2010.
36. Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio AL, McKenna WJ, Falaschi A, Giacca M and Camerini: Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 34: 181-190, 1999.
37. Suzuki E, Evans T, Lowry J, Truong L, Bell DW, Testa JR and Walsh K: The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics 38: 283-290, 1996.
38. Rémond MC, Iaffaldano G, O'Quinn MP, Mezentseva NV, Garcia V, Harris BS, Gourdie RG, Eisenberg CA and Eisenberg LM: GATA6 reporter gene reveals myocardial pheno-typic heterogeneity that is related to variations in gap junction coupling. Am J Physiol Heart Circ Physiol 301: H1952-H1964, 2011.
39. Peterkin T, Gibson A and Patient R: GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation. EMBO J 22: 4260-4273, 2003.
40. Holtzinger A and Evans T: Gata5 and Gata6 are functionally redundant in zebrafish for specification of cardiomyocytes. Dev Biol 312: 613-622, 2007.
41. Koutsourakis M, Langeveld A, Patient R, Beddington R and Grosveld F: The transcription factor GATA6 is essential for early extraembryonic development. Development 126: 723-732, 1999.
42. Xin M, Davis CA, Molkentin JD, Lien CL, Duncan SA, Richardson JA and Olson EN: A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci USA 103: 11189-11194, 2006.
43. Zhao R, Watt AJ, Battle MA, Li J, Bondow BJ and Duncan SA: Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol 317: 614-619, 2008.
44. Costa MW, Guo G, Wolstein O, Vale M, Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M, Semsarian C, Weintraub RG, Yeoh T, Hayward C, Keogh A, Macdonald P, Feneley M, Graham RM, Seidman JG, Seidman CE, Rosenthal N, Fatkin D and Harvey RP: Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy. Circ Cardiovasc Genet 6: 238-247, 2013.
45. Kirk EP, Sunde M, Costa MW, Rankin SA, Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, Mackay JP, Waddell LB, Cole AD, Hayward C, Keogh A, Macdonald P, Griffiths L, Fatkin D, Sholler GF, Zorn AM, Feneley MP, Winlaw DS and Harvey RP: Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 81: 280-291, 2007.
46. Yang YQ, Wang J, Wang XH, Wang Q, Tan HW, Zhang M, Shen FF, Jiang JQ, Fang WY and Liu X: Mutational spectrum of the GATA5 gene associated with familial atrial fibrillation. Int J Cardiol 157: 305-307, 2012.
47. Gu JY, Xu JH, Yu H and Yang YQ: Novel GATA5 loss-of-function mutations underlie familial atrial fibrillation. Clinics (Sao Paulo) 67: 1393-1399, 2012.
48. Wang XH, Huang CX, Wang Q, Li RG, Xu YJ, Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation underlies lone atrial fibrillation. Int J Mol Med 31: 43-50, 2013.
49. Huang RT, Xue S, Xu YJ, Zhou M and Yang YQ: A novel NKX2.5 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med 31: 1119-1126, 2013.
50. Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation. Clinics (Sao Paulo) 68: 777-784, 2013.
51. Yang YQ, Xu YJ, Li RG, Qu XK, Fang WY and Liu X: Prevalence and spectrum of PITX2c mutations associated with familial atrial fibrillation. Int J Cardiol 168: 2873-2876, 2013.
52. Zhou YM, Zheng PX, Yang YQ, Ge ZM and Kang WQ: A novel PITX2c loss-of-function mutation underlies lone atrial fibrillation. Int J Mol Med 32: 827-834, 2013.
53. Wang J, Zhang DF, Sun YM and Yang YQ: A novel PITX2c loss-of-function mutation associated with familial atrial fibrillation. Eur J Med Genet 57: 25-31, 2014.